v3.26.1
Collaboration Agreements - Additional Information (Details) 1
$ in Millions
Jun. 30, 2026
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-07-01 | Novartis Collaboration Agreement  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining transaction price $ 10.5
Remaining transaction price recognized period 1 year 9 months
Remaining transaction price recognized year 2027
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-07-01 | Amgen Collaboration Agreement  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining transaction price $ 1.7
Remaining transaction price recognized period 9 months
Remaining transaction price recognized year 2027